Genetic modeling of human urinary bladder carcinogenesis

Genes Chromosomes and Cancer

Volumn 27, Issue 4, 2000, Pages 392-402

  Czerniak, Bogdan ^a   Li, Li ^a   Chaturvedi, Vijaya ^a   Ro, J Y ^a   Johnston, Dennis A ^a   Hodges, Sherie ^a   Benedict, William F ^a  

^a UNIVERSITY OF TEXAS   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DNA;

ADULT; AGED; ALLELE; ARTICLE; BLADDER CANCER; BLADDER CARCINOGENESIS; CHROMOSOME; CONTROLLED STUDY; CYSTECTOMY; GENE MAPPING; HETEROZYGOSITY LOSS; HUMAN; HUMAN TISSUE; MALE; MODEL; PRIORITY JOURNAL; TUMOR SUPPRESSOR GENE;

AGED; CARCINOMA, TRANSITIONAL CELL; CHROMOSOME MAPPING; DNA, NEOPLASM; GENETIC MARKERS; HUMANS; LOD SCORE; LOSS OF HETEROZYGOSITY; MALE; MIDDLE AGED; MODELS, GENETIC; URINARY BLADDER NEOPLASMS;

EID: 0034101755     PISSN: 10452257     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1098-2264(200004)27:4<392::AID-GCC9>3.0.CO;2-N     Document Type: Article

References (30)

1. Cairns P, Shaw ME, Knowles MA. 1993. Preliminary mapping of the deleted region of chromosome 9 in bladder cancer. Cancer Res 53:1230-1232.
2. Chaturvedi V, Li L, Hodges S, Johnston D, Ro JY, Logothetis C, von Eschenbach AC, Batsakis JG, Czerniak B. 1997. Superimposed histologic and genetic mapping of chromosome 17 alterations in human urinary bladder neoplasia. Oncogene 14:2059-2070.
3. Collins FS. 1992. Positional cloning: let's not call it reverse anymore. Nature Genet 1:3-6.
4. Collins FS. 1995. Positional cloning moves from perditional to traditional. Nature Genet 9:347-350.
5. Cordon-Cardo C, Sheinfeld J, Dalbagni G. 1997. Genetic studies and molecular markers of bladder cancer. Semin Surg Oncol 13:319-327.
6. Czerniak B, Herz F. 1995. Molecular biology of urinary bladder cancer. In: Koss LG, editor. Diagnostic cytology of the urinary tract with histopathologic and clinical correlations. Philadelphia: Lippincott-Raven; p 345-359.
7. Czerniak B, Chaturvedi V, Li L, Hodges S, Johnston D, Ro JY, Luthra R, Logothetis C, von Eschenbach AC, Grossman B, Benedict WF, Batsakis JG. 1999. Superimposed histologic and genetic mapping of chromosome 9 in progression of human urinary bladder neoplasia: implications for a genetic model of multistep urothelial carcinogenesis and early detection of urinary bladder cancer. Oncogene 18:1185-1196.
8. Dib C, Faure S, Fizames C, Samson D, Drouot N, Vignal A, Millasseau P, Marc S, Hazan J, Seboun E, Lathrop M, Gyapay G, Morissette J, Weissenbach J. 1996. A comprehensive genetic map of the human genome based on 5,264 micosatellites. Nature (London) 380:152-154.
9. Habuchi T, Ogawa O, Kakehi Y, Ogura K, Koshiba M, Hamazaki S, Takahashi R, Sugiyama T, Yoshida O. 1993. Accumulated allelic losses in the development of invasive urothelial cancer. Int J Cancer 53:579-584.
10. Hartigan JA. 1975. Clustering algorithms. New York: John Wiley & Sons, Inc.
11. Johansson B, Mertens F, Mitelman F. 1996. Primary vs. secondary neoplasia-associated chromosomal abnormalities - balanced rearrangements vs. genomic imbalances. Genes Chromosomes Cancer 16:155-163.
12. Kinzler KW, Vogelstein B. 1996. Lessons from hereditary colorectal cancer. Cell 87:159-170.
13. Koss LG, Czerniak B. 1991. Biology and management of urinary bladder cancer (letter). N Engl J Med 324:125-126.
14. Koss LG, Tiamson EM Robbins MA. 1974. Mapping cancerous and precancerous bladder changes. A study of the urothelium in ten surgically removed bladders. JAMA 227:281-286.
15. Koss LG, Nakanishi I, Freed, SZ. 1977. Non-papillary carcinoma in situ and atypical hyperplasia in cancerous bladders: further studies of surgically removed bladders by mapping. Urology 9:442-455.
16. Landis SH, Murray T, Bolden S, Wingo PA. 1999. Cancer statistics. Cancer J Clin 49:8-31.
17. Linnenbach AJ, Pressler LB, Seng BA, Kimmel BS, Tomaszewski JE. Malkowicz SB. 1993. Characterization of chromosome 9 deletions in transitional cell carcinoma by microsatellite assay. Hum Molecular Genet 2:1407-1411.
18. Lynch CF, Cohen, MB. 1995. Urinary system. Cancer 75(Suppl):316-329.
19. Mao L, Schoenberg MP, Scicchitano M, Erozan YS, Merlo A, Schwab D, Sidransky D. 1996. Molecular detection of primary bladder cancer by microsatellite analysis. Science 271:659-662.
20. Mostofi FK, Sobin LH, Torloni H. 1973. Histological typing of urinary bladder tumors. In: International histological classification of tumors, No. 10 Geneva: WHO.
21. Ott J. 1991. Analysis of human genetic linkage. Baltimore: Johns Hopkins University Press.
22. Parker SL, Tong T, Bolden S, Wingo PA. 1997. Cancer statistics. Cancer J Clin 47:5-27.
23. Ross RK, Jones PA, Yu MC. 1996. Bladder cancer epidemiology and pathogenesis. Semin Oncol 23:536-545.
24. Sandberg AA, Berger CS. 1994. Review of chromosome studies in urological tumors. II. Cytogenetics and molecular genetics of bladder cancer. J Urol 151:545-560.
25. Shirai T, Fradet Y, Huland H, Bollack C, Droller M, Janknegt R. Jones P, Kagawa S. 1995. The etiology of bladder cancer - are there any new clues or predictors of behavior? Int J Urol 2:64-75.
26. Sidransky D, Messing E. 1992. Molecular genetics and biochemical mechanisms in bladder cancer. Oncogenes, tumor suppressor genes, and growth factors. Urol Clin N Am 19:629-639.
27. Simoneau AR, Jones PA. 1994. Bladder cancer: the molecular progression to invasive disease. World J Urol 12:89-95.
28. Steiner G, Schoenberg MP, Linn JF, Mao L, Sidransky D. 1997. Detection of bladder cancer recurrence by microsatellite analysis of urine. Nature Med 3:621-624.
29. Spruck CH 3rd, Ohneseit PF, Gonzalez-Zulueta M, Esrig D, Miyao N, Tsai YC, Lerner SP, Schmutte C, Yang AS, Cote R, Dubeau L, Nichols PW, Hermann GG, Steven K, Horn T, Skinner DG, Jones PA. 1994. Two molecular pathways to transitional cell carcinoma of the bladder. Cancer Res 54:784-788.
30. Tsai YC, Nichols PW, Hiti AL, Wiliams Z, Skinner DG, Vanni R, Scarpa RM, Nieddu M, Usai E. 1988. Allelic losses of chromosomes 9, 11, and 17 in human bladder cancer. Cancer Genet Cytogenet 50:44-47.